Can we "hedge" against the development of antiviral resistance among pandemic influenza viruses?

PLoS Medicine

Volumn 6, Issue 6, 2009, Pages

  Shay, David K ^a   Ridenhour, Benjamin J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

ANTIVIRAL RESISTANCE; DISEASE PREDISPOSITION; DISEASE SIMULATION; HEALTH CARE POLICY; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; MONOTHERAPY; MUTATIONAL ANALYSIS; PANDEMIC; SHORT SURVEY; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; DISEASE OUTBREAKS; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; HEALTH POLICY; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; OSELTAMIVIR;

EID: 67650272787     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000103     Document Type: Short Survey

References (8)

1. Wu JT, Leung GM, Lipsitch M, Cooper BS, Riley S (2009) Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy. PLoS Med 6: e1000085. doi:10.1371/journal.pmed. 1000085.
2. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med, Epub ahead of print. doi:10.1056/NEJMoa0903810.
3. Goossens H (2009) Antibiotic consumption and link to resistance. Clin Microbiol Infect 15(Suppl 3): 12-15.
4. Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, et al. (2006) Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 50: 2395-2402.
5. Herlocher ML, Truscon R, Fenton R, Klimov A, Elias S, et al. (2003) Assessment of development of resistance to antivirals in the ferret model of influenza virus infection. J Infect Dis 188: 1355-1361.
6. Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, et al. (2009) Oseltamivir-Resistance Working Group. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 301: 1034-1041.
7. Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O (2009) Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis 15: 155-162.
8. Ilyushina NA, Bovin NV, Webster RG, Govorkova EA (2006) Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants. Antiviral Res 70: 121-131.